ALL KEYWORDSHodgkin LymphomaRelated SpecialistsScott HuntingtonMD, MPH, MScFrancine FossMDStuart SeropianMDRelated Fact SheetsHodgkin's LymphomaRelated Clinical TrialsPhase 2 Study of Pembrolizumab and Brentuximab Vedotin in Subjects With Relapsed/Refractory CD30 Positive T-cell LymphomaLymphomaRelated DepartmentsShowing 3 of 4Leukemia & Lymphoma ProgramYale Cancer CenterInternal MedicineMore Related Departments
